Market News / Story
Lunai Bioworks asks Nasdaq to halt trading amid alleged irregular short-selling
·
Lunai Bioworks requested Nasdaq immediately suspend trading in its common stock while alleged irregular trading is reviewed. Key Highlights: Submitted urgent request to Nasdaq to suspend trading to protect investors pending review of trading records. Records from court-ordered discovery cite substantial short selling, locate deficiencies and concentrated failures to deliver. Allegations arise from pending litigation against Seven Points Capital and others in D. Del.;…